Average Co-Inventor Count = 5.10
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (29 from 4,770 patents)
2. Merck Sharp + Dohme Corp. (11 from 2,405 patents)
3. Other (2 from 832,843 patents)
4. Merck Canada Inc. (1 from 40 patents)
42 patents:
1. 10221186 - Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors
2. 9951079 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
3. 9861620 - Substituted quinolizine derivatives useful as HIV integrase inhibitors
4. 9714243 - 4-pyridinonetriazine derivatives as HIV integrase inhibitors
5. 9707234 - Spirocyclic hetercycle compounds useful as HIV integrase inhibitors
6. 9643982 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
7. 9493479 - Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors
8. 9145391 - Bipyridylaminopyridines as Syk inhibitors
9. 8513234 - HIV integrase inhibitors
10. 8293731 - HIV integrase inhibitors
11. 7820680 - HIV integrase inhibitors
12. 7741315 - HIV integrase inhibitors
13. 7619086 - HIV integrase inhibitors
14. 7598264 - HIV integrase inhibitors
15. 7538112 - HIV integrase inhibitors